Tunable Nanostructured Coating for the Capture and Selective Release of Viable Circulating Tumor Cells
Nicola Aceto(University of Basel), Eduardo Reátegui(The Ohio State University), Aditya Bardia(UCLA Health), Daniel A. Haber(Howard Hughes Medical Institute), Alexander J. Aranyosi(Massachusetts General Hospital), Eugene J. Lim(Boston University), Mahnaz Zeinali(Massachusetts General Hospital), Steven Castleberry(Massachusetts Institute of Technology), Paula T. Hammond(Massachusetts Institute of Technology), Shyamala Maheswaran(Massachusetts General Hospital), Shannon L. Stott(Shriners Hospitals for Children - Erie), Lecia V. Sequist(Harvard University), Mehmet Toner(Shriners Hospitals for Children - Erie), Wěi Li(Central South University), Anne Eeg Jensen(Harvard University), Joseph M. Martel(Boston University), James P. Sullivan(Australian National University)
DSpace@MIT (Massachusetts Institute of Technology)
January 1, 2015
Cited by 31
Related Papers
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k